Irbesartan is an angiotensin II receptor antagonist used mainly for the coarse of action of hypertension. Irbesartan was found by Sanofi Locate (okay, a portion of Sanofi-Aventis). These are jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade list Aprovel®, Karvea®, & Avapro®.

Irbesartan is one of a class that patients can be prescribed in case it just can't tolerate a ACE-inhibitor doses, like perindopril. A common understanding is because of dry cough, attributed to delayed breakdown of bradykinin by ACE. Irbesartan can support to delay a progression of diabetic nephropathy, a form of chronic renal failure due to diabetes.